Cite
HARVARD Citation
Berger, R. et al. (2022). Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab. Journal for immunotherapy of cancer. 10 (12), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Berger, R. et al. (2022). Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab. Journal for immunotherapy of cancer. 10 (12), p. . [Online].